Subtitle
Second tumor risk in children treated with proton therapy.
Subtitle
Second tumor risk in children treated with proton therapy.
Proto therapy Time
February 2021
Executive summary
Published in Pediatric Blood & Cancer, this study by the Jacksonville group evaluated the secondary tumor risk based on the data of 1713 children that underwent treatment with proton therapy. 11 patients developed secondary tumors.
Excluding patients with tumor predisposition syndromes, the 5- and 10-year rates were 0.6% and 1.7%. The authors conclude that secondary tumors are rare within the decade following proton therapy, particularly among children irradiated at >5 years old and those without tumor predisposition syndrome.
Key content topics
Top cancer treatments
Related contents
Proton Therapy Publication
May 2022
Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk.
Proton Therapy Publication
September 2021
Bicentric Treatment Outcomes following PT for Non-Myxopapillary High-Grade Spinal Cord Ependymoma in Children
Proton Therapy Publication
August 2021
Young Adult Populations Face Yet Another Barrier to Care with Insurers: Limited Access to Proton Therapy.
Proton Therapy Publication
July 2021
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence
Proton Therapy Publication
July 2021
Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in paediatric abdominal neuroblastoma
Proton Therapy Publication
June 2021
Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers
Proton Therapy Publication
April 2021
Comparing second cancer risk for multiple radiotherapy modalities in survivors of Hodgkin lymphoma
Proton Therapy Publication
October 2020
Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk.
Proton Therapy Publication
October 2020
Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy.